Retina Research Institute, LLC

120 S Central Ave, Saint Louis, Missouri, United States

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

50.0%

Phase 1

25.0%

Phase 4

25.0%

Trial Status Distribution

Completed

50.0%

Terminated

25.0%

Unknown

25.0%

Clinical Trials

Trials sponsored by this organization (4)

Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period

Not Applicable

Completed

interventional

Aug 202177 participants

Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF

Not Applicable

Terminated

interventional

Sep 201310 participants

Short-term Clinical Effects of Intravitreal Aflibercept Injection 2.0mg as a Predictor of Long-term Results

Phase 4

Unknown

interventional

Oct 201222 participants

Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis Syndrome

Phase 1

Completed

interventional

Jun 20125 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations